165 related articles for article (PubMed ID: 27773816)
21. p42.3: a promising biomarker for the progression and prognosis of human colorectal cancer.
Yuan XS; Zhang Y; Guan XY; Dong B; Zhao M; Mao LL; Lu YY; Tian XY; Hao CY
J Cancer Res Clin Oncol; 2013 Jul; 139(7):1211-20. PubMed ID: 23576022
[TBL] [Abstract][Full Text] [Related]
22. NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis.
Wu Y; Fang G; Wang X; Wang H; Chen W; Li L; Ye T; Gong L; Ke C; Cai Y
Cancer Biomark; 2019; 24(1):61-70. PubMed ID: 30347601
[TBL] [Abstract][Full Text] [Related]
23. Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis.
Kitajima T; Toiyama Y; Tanaka K; Saigusa S; Kobayashi M; Inoue Y; Mohri Y; Kusunoki M
Anticancer Res; 2014 Oct; 34(10):5321-9. PubMed ID: 25275025
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling.
Jiang J; Yang X; He X; Ma W; Wang J; Zhou Q; Li M; Yu S
Chem Biol Interact; 2019 Apr; 302():74-82. PubMed ID: 30738779
[TBL] [Abstract][Full Text] [Related]
25. CREPT accelerates tumorigenesis by regulating the transcription of cell-cycle-related genes.
Lu D; Wu Y; Wang Y; Ren F; Wang D; Su F; Zhang Y; Yang X; Jin G; Hao X; He D; Zhai Y; Irwin DM; Hu J; Sung JJ; Yu J; Jia B; Chang Z
Cancer Cell; 2012 Jan; 21(1):92-104. PubMed ID: 22264791
[TBL] [Abstract][Full Text] [Related]
26. CREPT expression correlates with poor prognosis in patients with retroperitoneal leiomyosarcoma.
She Y; Liang J; Chen L; Qiu Y; Liu N; Zhao X; Huang X; Wang Y; Ren F; Chang Z; Li P
Int J Clin Exp Pathol; 2014; 7(10):6596-605. PubMed ID: 25400738
[TBL] [Abstract][Full Text] [Related]
27. High expression of ROR2 in cancer cell correlates with unfavorable prognosis in colorectal cancer.
Mei H; Lian S; Zhang S; Wang W; Mao Q; Wang H
Biochem Biophys Res Commun; 2014 Oct; 453(4):703-9. PubMed ID: 25301559
[TBL] [Abstract][Full Text] [Related]
28. ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer.
Ma F; Bi L; Yang G; Zhang M; Liu C; Zhao Y; Wang Y; Wang J; Bai Y; Zhang Y
Oncol Rep; 2014 Sep; 32(3):1071-7. PubMed ID: 25017610
[TBL] [Abstract][Full Text] [Related]
29. Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo.
Wang Q; Yang L; Hu X; Jiang Y; Hu Y; Liu Z; Liu J; Wen T; Ma Y; An G; Feng G
Oncotarget; 2017 Jan; 8(2):3441-3453. PubMed ID: 27966450
[TBL] [Abstract][Full Text] [Related]
30. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
Yi W; Xiao E; Ding R; Luo P; Yang Y
Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
[TBL] [Abstract][Full Text] [Related]
31. Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer.
Yan X; Huang L; Liu L; Qin H; Song Z
Cancer Med; 2018 Feb; 7(2):420-432. PubMed ID: 29341479
[TBL] [Abstract][Full Text] [Related]
32. The Effect of High CDC6 Levels on Predicting Poor Prognosis in Colorectal Cancer.
Yang C; Xie N; Luo Z; Ruan X; Zhang Y; Wang W; Huang Y
Chemotherapy; 2022; 67(1):47-56. PubMed ID: 35034031
[TBL] [Abstract][Full Text] [Related]
33. ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer.
Chen Y; Huang Y; Hou P; Zhang Z; Zhang Y; Wang W; Sun G; Xu L; Zhou J; Bai J; Zheng J
Oncotarget; 2016 Nov; 7(48):79017-79031. PubMed ID: 27806345
[TBL] [Abstract][Full Text] [Related]
34. GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFβR2 in colorectal cancer.
Nambara S; Masuda T; Kobayashi Y; Sato K; Tobo T; Koike K; Noda M; Ogawa Y; Kuroda Y; Ito S; Eguchi H; Sugimachi K; Mimori K
Cancer Sci; 2020 Feb; 111(2):343-355. PubMed ID: 31758608
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk.
Ye Y; Xiao L; Wang SJ; Yue W; Yin QS; Sun MY; Xia W; Shao ZY; Zhang H
Oncotarget; 2016 Jan; 7(4):3921-33. PubMed ID: 26646797
[TBL] [Abstract][Full Text] [Related]
36. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
Li C; Cai S; Wang X; Jiang Z
Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
[TBL] [Abstract][Full Text] [Related]
39. High expression of Zinc-finger protein X-linked promotes tumor growth and predicts a poor outcome for stage II/III colorectal cancer patients.
Yan X; Shan Z; Yan L; Zhu Q; Liu L; Xu B; Liu S; Jin Z; Gao Y
Oncotarget; 2016 Apr; 7(15):19680-92. PubMed ID: 26967242
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
Huang Y; Xiao W; Jiang X; Li H
Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
